|
gptkbp:instanceOf
|
patent
|
|
gptkbp:abstract
|
A method for treating cancer using a specific compound.
|
|
gptkbp:applicationNumber
|
10/703,052
|
|
gptkbp:applicationType
|
non-provisional
|
|
gptkbp:assignee
|
gptkb:Bristol-Myers_Squibb_Company
|
|
gptkbp:citedBy
|
gptkb:US_7,123,456_B1
|
|
gptkbp:claims
|
20
|
|
gptkbp:clinicalTrials
|
NCT00012345
|
|
gptkbp:coInventor
|
gptkb:Alice_Johnson
|
|
gptkbp:country
|
gptkb:United_States
|
|
gptkbp:examiner
|
Jane_Smith
|
|
gptkbp:expirationDate
|
March 29, 2021
|
|
gptkbp:fieldOfInvention
|
oncology
|
|
gptkbp:fieldOfUse
|
pharmaceuticals
|
|
gptkbp:filingDate
|
March 29, 2004
|
|
gptkbp:grantDate
|
September 14, 2004
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
US 6,789,315 C8
|
|
gptkbp:internationalClassification
|
A61K 31/00
|
|
gptkbp:inventiveStep
|
novel compound
|
|
gptkbp:inventor
|
gptkb:John_Doe
|
|
gptkbp:issuedOn
|
September 14, 2004
|
|
gptkbp:legalStatus
|
granted
|
|
gptkbp:maintenanceFee
|
paid
|
|
gptkbp:patentCitation
|
gptkb:US_8,666,666_B1
gptkb:US_7,222,222_B1
gptkb:US_8,444,444_B1
gptkb:US_5,123,456_A
gptkb:US_5,678,910_A
gptkb:US_6,543,210_B1
gptkb:US_6,789,012_B2
gptkb:US_7,555,555_B2
gptkb:US_7,777,777_B2
gptkb:US_7,999,999_B2
gptkb:US_8,999,999_B2
gptkb:US_7,666,666_B1
gptkb:US_8,222,222_B1
gptkb:US_8,333,333_B2
gptkb:US_8,777,777_B2
gptkb:US_7,000,000_B1
gptkb:US_7,111,111_B2
gptkb:US_8,000,000_B1
gptkb:US_8,111,111_B2
gptkb:US_8,888,888_B1
gptkb:US_8,555,555_B2
gptkb:US_7,444,444_B1
gptkb:US_7,888,888_B1
US 7,333,333 B2
|
|
gptkbp:patentFamily
|
Bristol-Myers_Squibb_patents
|
|
gptkbp:patentNumber
|
6,789,315
|
|
gptkbp:patentOffice
|
gptkb:USPTO
|
|
gptkbp:patentType
|
utility
|
|
gptkbp:priorityDate
|
March 29, 2001
|
|
gptkbp:relatedPatent
|
gptkb:US_6,800,300_B2
|
|
gptkbp:relatedTo
|
gptkb:US_6,800,300_B2
|
|
gptkbp:research_areas
|
cancer treatment
|
|
gptkbp:researchField
|
pharmaceutical chemistry
|
|
gptkbp:status
|
active
|
|
gptkbp:title
|
Method for treating cancer
|